Study Bolsters Patient-Controlled Analgesia for Cancer Pain

AAPM member Kenneth Candido, MD, comments on a study regarding patient-controlled analgesia (PCA) IV hydromorphone titration provides quicker analgesic effect, higher patient satisfaction and a similar tolerability compared with non-PCA administration in patients with severe cancer pain. The findings come from a phase 3, randomized clinical trial involving 214 patients that was presented at the American Society of Clinical Oncology. Read more.